GROUP 2 PULMONARY HYPERTENSION
Clinical trials for GROUP 2 PULMONARY HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new GROUP 2 PULMONARY HYPERTENSION trials appear
Sign up with your email to follow new studies for GROUP 2 PULMONARY HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to ease double Heart-Lung strain
Disease control Recruiting nowThis study tests whether adding a second drug (macitentan) to a standard heart failure medicine (dapagliflozin) works better than the standard medicine alone. About 64 adults in South Korea with heart failure and a specific type of high blood pressure in the lungs will take the p…
Matched conditions: GROUP 2 PULMONARY HYPERTENSION
Phase: PHASE4 • Sponsor: Gachon University Gil Medical Center • Aim: Disease control
Last updated May 17, 2026 00:51 UTC
-
New procedure aims to improve quality of life for heart failure patients
Symptom relief Recruiting nowThis early study tests a procedure called pulmonary artery denervation in 50 people with heart failure and a type of lung hypertension (Group 2). The goal is to see if it can improve quality of life by reducing pressure in the lung arteries. Participants must have stable heart fa…
Matched conditions: GROUP 2 PULMONARY HYPERTENSION
Phase: NA • Sponsor: Gradient Denervation Technologies • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC